Effect of nucleos(t)ide analogue on serum HBsAg level in chronic hepatitis B patients: A 3-years study

We aim to explore the effects of nucleos(t)ide analogues (NUCs) on the changes of HBsAg in chronic hepatitis B (CHB) patients. A total of 264 CHB patients were enrolled in our study. All of them were treated with NUCs for at least three years. Quantification of HBsAg levels were measured by Elecsys...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biomedicine & pharmacotherapy 2020-02, Vol.122, p.109698-109698, Article 109698
Hauptverfasser:	Zheng, Zhidan, Liao, Wei, Liu, Lili, Cai, Shaohang, Zhu, Haipeng, Yin, Sichun
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral treatment Chronic hepatitis B HBsAg decline Life Sciences & Biomedicine Medicine, Research & Experimental Nucleoside analogues Pharmacology & Pharmacy Research & Experimental Medicine Science & Technology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!